Form 4 for MRNA Moderna
Accepted 2026-05-22 19:00:04 ET · period of report 2026-05-21 · accession 0001193125-26-237309 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-05-22 19:00 | 2026-05-21 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $19.15 | +9,263 | 13.2K | +236% | +$177.4K |
| DI | 2026-05-22 19:00 | 2026-05-21 | MRNA | AFEYAN NOUBAR | Dir | S - Sale+OE | $46.84 | -9,263 | 3,924 | -70% | -$433.9K |
| DI | 2026-05-22 19:00 | 2026-05-21 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $0.00 | -9,263 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 9,263 | $19.15 | 13,187 | I By Flagship Pioneering, LLC | — | — | (F1) On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2026-05-21 | S | D | 9,263 | $46.84 | 3,924 | I By Flagship Pioneering, LLC | — | — | (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-21 | M | D | 9,263 | $0.00 | 0 | I By Flagship Pioneering, LLC | $19.15 · — to 2026-08-10 | 9,263 Common Stock | (F1) On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. (F5) The options were fully vested and exercisable. (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |